Hikma To Buy Bedford, Transfer Manufacturing For U.S. Generics Injectables
This article was originally published in The Pink Sheet Daily
Executive Summary
Ben Venue’s shuttered Ohio plant is also slated to be part of the transaction, but Hikma’s initial focus is on moving acquired assets into its production facilities, even though the Jordan-based firm expects only limited revenue from them over the next two years.